Company:  ACORDA THERAPEUTICS INC (ACOR)
Form Type:  8-K
Filing Date:  12/7/2017 
CIK:  0001008848 
Address:  420 SAW MILL RIVER ROAD 
City, State, Zip:  ARDSLEY, New York 10502 
Telephone:  914-347-4300 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$28.75  
Change: 
-0.40 (-1.37%)  
Trade Time: 
Jul 20  
Market Cap: 
$1.35B
Trade ACOR now with 

© 2018  
Description of Business
We are a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. We market two U.S. Food and Drug Administration (FDA)-approved therapies, including Ampyra (dalfampridine) Extended Release Tablets, 10mg, a treatment to improve walking in adult patients with multiple sclerosis, or MS, as demonstrated by an increase in walking speed. Ampyra 2017 net revenue was $543 million, an increase of approximately 10% over 2016. We have a pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease and MS. We currently derive substantially all our revenue from the sale of Ampyra.
Register and access this filing in:     
  FORM 8-K
    SECTION 8 OTHER EVENTS
      Item 8.01Other Events
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01Financial Statements and Exhibits
    SIGNATURES
  EXHIBIT 99.1